"Clinical Trials in Russia”, summary by EA, August 2011

Russia is one of the most attractive regions to conduct clinical trials. There are several advantages to place clinical trials in this area:
  • Population size of 141,8 million, providing access to a large potential pool of mostly treatment naive clinical trial subjects
  • Centralized healthcare system with the developed referral network and a number of private practices. As a result - few sites needed to get a large number of patients
  • Good selection of high-quality investigational sites
  • ICH-GCP compliance principles incorporated into legislation
  • High recruitment rates with low drop-out rates: Patient recruitment rates in the region is up to 10 times higher than in US and EU
  • Savings in costs: Average cost per patient in Eastern Europe is 28% lower than in Western Europe and 47% than in the UK
  • Possibility to reduce clinical trial expenditure by using local CROs and labs
  • High qualification level of investigators for conducting clinical trials. All of the investigators are medical doctors; many speak English fluently, attend international conferences, and are members of European and American professional societies. Clinicians are GCP experienced. Over 60% of clinical investigators have PhD credentials with some 40% of them teaching at major universities.
Read this whitepaper in PDF format
  Disclaimer | Privacy Policy | Site Map